, Tracking Stock Market Picks
Enter Symbol:
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

up 177.62 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Overweight with price target $84 by Barclays Capital

Posted on: Friday,  Feb 10, 2012  12:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 02/10/2012. Previously Barclays Capital rated Overweight Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on
12/09/2011., when the stock price was $64.77. Since then, Alexion Pharmaceuticals, Inc. has gained 177.63% as of 12/11/2015's recent price of $179.82.
If you would have followed the previous Barclays Capital's recommendation on ALXN, you would have gained 177.62% of your investment in 1463 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2012 12:25 PM Buy
82.72 84.00
as of 12/31/2012
1 Week down  -1.72 %
1 Month down  -2.37 %
3 Months down  -18.05 %
1 YTD up  31.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2011 12:25 PM Buy
64.77 77.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy